However, we cannot rule out that the mechanism of action on different cell types (e.g. hepatic, pancreatic, tumor, muscles) of a pan‐PI3K/mTOR inhibitor leads to fundamentally different outcomes with respect to the effect on biochemical carbon homeostasis when compared to single‐node PAM inhibitors. Here, PIK3CA is linked to neoplasm.